Company profile
Boston Scientific Corporation
NYSE: BSX · Healthcare · Medical - Devices
#28 of 1,422 Healthcare companies by revenue66th-percentile growth
EA Score
88AFH 89DQ 91GM 74SS 98
v0.1 · 65/100 weight · provisional
↑ market scale, workforce scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$20.6B
Rev growth YoY (TTM)
+17.4%
Net income (FY)
$2.9B
Employees
59,000
as of 2026-08-04
Market cap
$72.0B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$20.1B$20.1B2025
Net income$2.9B$2.9B2025
Operating income$3.6B$3.6B2025
Total assets$43.7B$43.7B2025
Equity$24.2B$24.2B2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Cardiovascular66%
MedSurg34%
By geography
UNITED STATES64%
Non-US36%
The read
What is Boston Scientific Corporation’s revenue?
Boston Scientific Corporation booked $20.1B in FY2025 revenue, growing 20% year over year — faster than most Healthcare companies we track, at a 14.4% net margin.
Peers · Healthcare
Becton, Dickinson and Company84B+Tenet Healthcare Corporation78B+GE HealthCare Technologies Inc.69BUniversal Health Services, Inc.83B+IQVIA Holdings Inc.79B+Regeneron Pharmaceuticals, Inc.85ANeighbors
Middlesex →Key facts
CEOMichael F. Mahoney
SectorHealthcare
IndustryMedical - Devices
HeadquartersMarlborough, MA
ExchangeNYSE: BSX
Employees59,000
IPO date1992-05-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.